Scientists reveals how cancer-causing p53 mutations remain invisible to the immune system
One of the biggest challenges in cancer immunotherapy may not be that immune cells are too weak, but…
FDA clears trial of dual-targeted CAR T-cell therapy for cancer
The U.S. Food and Drug Administration this week granted permission for investigators at the University of Colorado Anschutz to…
Scientists traced a hidden immune route that may worsen tau-linked brain damage
Researchers traced an immune pathway from brain-draining lymph nodes to tau-affected tissue, revealing how peripheral immune activity may…
Polydatin reduces ulcerative colitis by regulating intestinal immune cells
Ulcerative colitis (UC) is a chronic inflammatory bowel disease in which recurrent intestinal inflammation can be difficult to…
New gene signature predicts immunotherapy success for bone marrow cancers
A team led by researchers from the German Cancer Research Center (DKFZ), the HI-STEMÂ Stem Cell Institute, and Medical…
New study redefines high risk criteria for multiple myeloma
Researchers have found that with new treatments for multiple myeloma, a serious type of blood cancer, clinicians should…
KAIST study opens a new avenue for treating intractable brain tumors
Researchers have uncovered a clue to why immune checkpoint inhibitors-cancer therapies that release the immune “brakes” exploited by…
Probiotic metabolite found to suppress melanoma tumor growth in mice
Immune checkpoint inhibitors like anti-PD-1 have transformed melanoma treatment, yet more than half of patients fail to respond…
AI-designed molecular switch uses caffeine to control engineered cells
For many of us, a warm cup of coffee is how we start our day. For Texas A&M…
Roswell Park scientists present five key cancer studies at clinical meeting
The research findings of experts from Roswell Park Comprehensive Cancer Center will be featured during the American Society…
Small T-cell subset drives powerful multiple myeloma immunotherapy responses
Researchers from The University of Osaka find that only a small fraction of T cells may drive the…
New mRNA vaccine strategy dramatically amplifies cancer-fighting T cells
Engineers from the University of Houston, MIT and Harvard have developed a new mRNA-based strategy that dramatically amplifies…